NVR Form 144 Notice — 50 Common Shares Planned Sale on 08/22/2025

Rhea-AI Filing Summary

NVR, Inc. (Form 144) notice shows a proposed sale of 50 common shares through UBS Financial Services, listed on the NYSE, with an aggregate market value of $411,586.95 and 2,870,000 shares outstanding. The listed approximate sale date is 08/22/2025. The filing reports the shares were acquired in open-market transactions: 30 shares on 10/23/2020 (paid in cash) and 20 shares on 05/20/2018 (paid in cash). The filer states there were no securities sold in the past three months and affirms no undisclosed material adverse information is known.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for a small block of insider-held common shares to be sold through UBS on 08/22/2025.

This filing documents a proposed sale under Rule 144 of 50 common shares with an aggregate market value of $411,586.95 executed through UBS Financial Services and scheduled for 08/22/2025. The shares were acquired in open-market transactions in 2018 and 2020 and paid in cash. The filer reports no sales in the past three months, which suggests this is an isolated planned disposition rather than part of frequent trading activity. For investors, the filing is a standard compliance disclosure and does not include operating or financial performance data.

Compliance / Risk Analyst

TL;DR: Filing appears complete for Rule 144 requirements and includes necessary acquisition and broker details.

The notice provides required elements: broker name and address, number of shares to be sold, acquisition dates and payment method, and a statement about lack of undisclosed material information. It also states there were no sales in the prior three months. From a compliance perspective, the form meets disclosure expectations for a Rule 144 sale; no indications of missing mandatory fields are present in the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	50	411586.95	2870000	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/23/2020	Open Market	Open Market			30	10/23/2020	Cash
Common	05/20/2018	Open Market	Open Market			20	05/20/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NVR (NVR) Form 144 disclose?

The Form 144 discloses a proposed sale of 50 common shares through UBS Financial Services with an aggregate market value of $411,586.95 and an approximate sale date of 08/22/2025.

Who is the broker handling the sale in the NVR Form 144?

UBS Financial Services Inc., 1000 Harbor Blvd 3rd Floor, Weehawken, NJ is listed as the broker for the proposed sale.

When were the shares to be sold acquired according to the filing?

30 shares were acquired on 10/23/2020 and 20 shares were acquired on 05/20/2018, both in open-market transactions and paid in cash.

Does the Form 144 report any sales by the filer in the prior three months?

No. The filing states 'Nothing to Report' for securities sold during the past three months.

What representation does the filer make about material information?

The filer represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.